Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Pluri Inc. before investing.

In this article, we go over a few key elements for understanding Pluri Inc.’s stock price such as:

• Pluri Inc.’s current stock price and volume
• Why Pluri Inc.’s stock price changed recently
• Upgrades and downgrades for PLUR from analysts
• PLUR’s stock price momentum as measured by its relative strength

About Pluri Inc. (PLUR)

Before we jump into Pluri Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and a novel immunotherapy platform. The company’s product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle injuries following hip fracture, acute respiratory distress syndrome due to COVID-19, peripheral artery disease, intermittent claudication, and critical limb ischemia; PLX-R18, is composed of fetal MSC like cells originating from the placenta for the treatment of hematopoietic complications of the H-ARS, and phase I trial to treat hematopoietic cell transplantation; and allogeneic MAIT cell therapy platform. It also offers cell manufacturing services; cell-based coffee; and develops and commercializes cultivated meat products. The company operates in the field of regenerative medicine, food-tech, CDMO, and agtech. It has collaboration agreement with Bar-Ilan University to advance cancer immunotherapy for solid tumors. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.

Want to learn more about Pluri Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Pluri Inc..

Pluri Inc.’s Stock Price as of Market Close

As of April 24, 2025, 12:27 PM, CST, Pluri Inc.’s stock price was $6.146.

Pluri Inc. is down 8.96% from its previous closing price of $6.750.

During the last market session, Pluri Inc.’s stock traded between $5.748 and $6.460. Currently, there are approximately 5.55 million shares outstanding for Pluri Inc..

Pluri Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Pluri Inc. Stock Price History

Pluri Inc.’s (PLUR) price is currently up 42.92% so far this month.

During the month of April, Pluri Inc.’s stock price has reached a high of $7.130 and a low of $3.330.

Over the last year, Pluri Inc. has hit prices as high as $7.130 and as low as $3.330. Year to date, Pluri Inc.’s stock is up 43.75%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Pluri Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 23, 2025, there were analysts who downgraded Pluri Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Pluri Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Pluri Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Pluri Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Pluri Inc. (PLUR) by visiting AAII Stock Evaluator.

Relative Price Strength of Pluri Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 23, 2025, Pluri Inc. has a weighted four-quarter relative price strength of 26.00%, which translates to a Momentum Score of 95 and is considered to be Very Strong.

Want to learn more about how Pluri Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Pluri Inc. Stock Price: Bottom Line

As of April 24, 2025, Pluri Inc.’s stock price is $6.146, which is down 8.96% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Pluri Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.